4 results  1 of 1 

1 Prevalence of PALB2 Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan
Muhammad Usman Rashid, Faiz Ali Khan, Noor Muhammad, Asif Loya, Ute Hamann
Cancer Res Treat.2019;51(3):992-1000.   Published online 2018 October 11     DOI: http://dx.doi.org/10.4143/crt.2018.356
      
2 Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers
Eun-Gyeong Lee, Hyok Jo Kang, Myong Cheol Lim, Boyoung Park, Soo Jin Park, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Sang-Yoon Park, Boram Park, Jungnam Joo, Jai Hong Han, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.2019;51(1):280-288.   Published online 2018 May 4     DOI: http://dx.doi.org/10.4143/crt.2018.079
      
3 Clinically Significant Unclassified Variants in BRCA1 and BRCA2 genes among Korean Breast Cancer Patients
Kyong-Ah Yoon, Boyoung Park, Byung Il Lee, Moon Jung Yang, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.2017;49(3):627-634.   Published online 2016 September 13     DOI: http://dx.doi.org/10.4143/crt.2016.292
      
4 Frequency of BRCA1 and BRCA2 Germline Mutations Detected by Protein Truncation Test and Cumulative Risks of Breast and Ovarian Cancer among Mutation Carriers in Japanese Breast Cancer Families
Noriko Ikeda, Yasuo Miyoshi, Noriko Ikeda, Kohri Yoneda, Moritoshi Kinoshita, Shinzaburo Noguchi
J Korean Breast Cancer Soc.2002;5(3):194-201.   Published online 2002 September 30     DOI: http://dx.doi.org/10.4048/jkbcs.2002.5.3.194
      

 1 of 1